WHO suggests that molnupiravir is only provided to non-severe COVID-19 patients with the highest risk of hospitalization - e.g. people who have not received a #COVID19 vaccination, older people, people with immunodeficiencies & people living with chronic diseases like diabetes https://t.co/RIh9Sxydfq— World Health Organization (WHO) (@WHO) March 3, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


